Marshall University scientist wins new NIH grant for research on heart attack

NewsGuard 100/100 Score

Sandrine Pierre, Ph.D., associate scientific director at the Marshall Institute for Interdisciplinary Research (MIIR), has received a new grant from the National Institutes of Health (NIH) to further her research on myocardial infarction, known as a heart attack.

Pierre received a $440,000 three-year NIH Research Enhancement Award (R15), designed to support small-scale research projects that strengthen the research environment of the institution. Through the grant, Pierre and her team will explore a new Na/K-ATPase/Src pathway as a target in ischemia/reperfusion injury to limit cardiac dysfunction in hopes of developing new therapeutic interventions for the treatment of myocardial infarction and heart failure.

Myocardial infarction remains the leading cause of mortality in industrialized nations, accounting for nearly 1 in 3 deaths in the United States, and resulting in significant disability among survivors. The study will test two distinct interventions in both the acute phase of myocardial infarction as well as the chronic phase of adverse cardiac remodeling, the phase which ultimately leads to heart failure in the growing number of individuals who survive a heart attack.

This study will build on Pierre's previous research that identified the cardioprotective properties of Na/K-ATPase signaling pathway in the cardiac myocyte.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses